CVS Health Corp vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? CVS Health Corp trades at $85.46 (market cap $112.29B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $212.87 (market cap $39.15B). The key difference: CVS Health Corp is far larger — about 2.9× TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock's market cap, and CVS Health Corp pays a 3.03% dividend while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock for 110 Days on average.
| CVS | TTWO | |
|---|---|---|
Market Cap | $112.29B | $39.15B |
Volume | 7,763,676 | 2,708,429 |
Sector | Health | Technology |
52-Week High | $110.60 | $262.29 |
52-Week Low | $70.08 | $189.69 |
Typical Hold Time | 83 Days | 110 Days |
Enterprise Value | $174.64B | $40.27B |
Dividend Yield | 3.03% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
Take-Two Interactive trades at $204.01, up 0.73% with mixed technical signals showing bearish moving averages but neutral oscillators. The company faces fundamental challenges with a net loss of -$4.48 billion in 2025 and negative profit margins, though revenue grew to $5.63 billion. Recent news highlights GTA VI's confirmed November 2026 launch date as a potential catalyst, while institutional buying and strong analyst support (79% buy ratings) suggest long-term confidence despite current profitability issues.
The outlook hinges on GTA VI's successful execution, with analyst consensus target at $292.30 representing 43% upside. Key risks include persistent negative cash flow from operations, high debt levels, and execution challenges in the competitive gaming sector. The stock offers substantial potential upside if management can translate strong franchises into sustainable profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →